Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

377 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Follow-up on patients with initial negative mpMRI target and systematic biopsy for PI-RADS ≥ 3 lesions - an EAU-YAU study enhancing prostate cancer detection.
Zattoni F, Gandaglia G, van den Bergh RCN, Marra G, Valerio M, Martini A, Olivier J, Puche-SanzI I, Rajwa P, Maggi M, Campi R, Nicoletti R, Amparore D, De Cillis S, Zhuang J, Guo H, Fuschi A, Veccia A, Ditonno F, Paulino Pereira LJ, Marquis A, Barletta F, Leni R, Kasivisvanathan V, Antonelli A, Rivas JG, Remmers S, Roobol MJ, Briganti A, Dal Moro F, Novara G. Zattoni F, et al. Among authors: campi r. Prostate Cancer Prostatic Dis. 2024 Nov 5. doi: 10.1038/s41391-024-00904-1. Online ahead of print. Prostate Cancer Prostatic Dis. 2024. PMID: 39501078
Overdiagnosis and stage migration of ISUP 2 disease due to mpMRI-targeted biopsy: facts or fictions.
Martini A, Touzani A, Mazzone E, Roumiguié M, Marra G, Valerio M, Beauval JB, Campi R, Minervini A, van den Berg RCN, Soeterik TFW, Zhuang J, Guo H, Gontero P, Montorsi F, Briganti A, Gandaglia G, Ploussard G; Young Academic Urologists Working Group on Prostate Cancer of the European Association of Urology. Martini A, et al. Among authors: campi r. Prostate Cancer Prostatic Dis. 2022 Apr;25(4):794-796. doi: 10.1038/s41391-022-00606-6. Epub 2022 Oct 8. Prostate Cancer Prostatic Dis. 2022. PMID: 36209238
The impact of a second MRI and re-biopsy in patients with initial negative mpMRI-targeted and systematic biopsy for PIRADS ≥ 3 lesions.
Zattoni F, Pereira LJP, Marra G, Valerio M, Olivier J, Puche-Sanz I, Rajwa P, Maggi M, Campi R, Amparore D, De Cillis S, Junlong Z, Guo H, La Bombarda G, Fuschi A, Veccia A, Ditonno F, Marquis A, Barletta F, Leni R, Serni S, Kasivisvanathan V, Antonelli A, Dal Moro F, Rivas JG, van den Bergh RCN, Briganti A, Gandaglia G, Novara G. Zattoni F, et al. Among authors: campi r. World J Urol. 2023 Nov;41(11):3357-3366. doi: 10.1007/s00345-023-04578-7. Epub 2023 Sep 27. World J Urol. 2023. PMID: 37755520 Free PMC article.
Correction to: Overdiagnosis and stage migration of ISUP 2 disease due to mpMRI-targeted biopsy: facts or fictions.
Martini A, Touzani A, Mazzone E, Roumiguié M, Marra G, Valerio M, Beauval JB, Campi R, Minervini A, van den Berg RCN, Soeterik TFW, Zhuang J, Guo H, Gontero P, Montorsi F, Briganti A, Gandaglia G, Ploussard G; Young Academic Urologists Working Group on Prostate Cancer of the European Association of Urology. Martini A, et al. Among authors: campi r. Prostate Cancer Prostatic Dis. 2023 Dec;26(4):806. doi: 10.1038/s41391-022-00637-z. Prostate Cancer Prostatic Dis. 2023. PMID: 36670304 No abstract available.
Observation With or Without Subsequent Salvage Therapy for Pathologically Node-positive Prostate Cancer With Negative Conventional Imaging: Results From a Large Multicenter Cohort.
Marra G, Lesma F, Montefusco G, Filippini C, Olivier J, Affentranger A, Grogg JB, Hermanns T, Afferi L, Fankhauser CD, Mattei A, Malkiewicz B, Scuderi S, Barletta F, Gallina S, Antonelli A, Zattoni F, Dal Moro F, Lieke W, Soeterik T, van den Bergh RCN, Rajwa P, Shariat SF, Rodriguez-Sanchez L, Nicoletti R, Campi R, Ahmed M, Jeffrey Karnes R, Ladurner M, Heidegger I, Briganti A, Gontero P, Gandaglia G; Young Academic Urologists Prostate Cancer Working Group. Marra G, et al. Among authors: campi r. Eur Urol Open Sci. 2024 Aug 22;68:32-39. doi: 10.1016/j.euros.2024.06.016. eCollection 2024 Oct. Eur Urol Open Sci. 2024. PMID: 39263349 Free PMC article.
Risk Stratification of Patients Candidate to Radical Prostatectomy Based on Clinical and Multiparametric Magnetic Resonance Imaging Parameters: Development and External Validation of Novel Risk Groups.
Mazzone E, Gandaglia G, Ploussard G, Marra G, Valerio M, Campi R, Mari A, Minervini A, Serni S, Moschini M, Marquis A, Beauval JB, van den Bergh R, Rahota RG, Soeterik T, Roumiguiè M, Afferi L, Zhuang J, Guo H, Mattei A, Gontero P, Cucchiara V, Stabile A, Fossati N, Montorsi F, Briganti A. Mazzone E, et al. Among authors: campi r. Eur Urol. 2022 Feb;81(2):193-203. doi: 10.1016/j.eururo.2021.07.027. Epub 2021 Aug 13. Eur Urol. 2022. PMID: 34399996
Impact of the time elapsed between prostate biopsy and surgery on the accuracy of nomograms predicting lymph node invasion in patients with clinically localized prostate cancer.
Pellegrino F, Mazzone E, Stabile A, Beauval JB, Marra G, Campi R, Afferi L, Zhuang J, Sorce G, Rosiello G, Barletta F, Scuderi S, Guo H, Gontero P, Minervini A, Ploussard G, Montorsi F, Briganti A, Gandaglia G. Pellegrino F, et al. Among authors: campi r. Urol Oncol. 2023 Sep;41(9):387.e17-387.e25. doi: 10.1016/j.urolonc.2023.04.019. Epub 2023 May 16. Urol Oncol. 2023. PMID: 37198026
Complication rate across the minimally invasive surgical treatments (MISTs): where do we stand? A systematic review of the literature.
Lambertini L, Sandulli A, Coco S, Paganelli D, Cadenar A, Dell'Oglio P, Puliatti S, Di Maida F, Grosso AA, Amparore D, Bertolo R, Campi R, Lombardo R, Ferro M, Rocco B, Vittori G, Antonelli A, De Nunzio C, Minervini A, Mari A. Lambertini L, et al. Among authors: campi r. Prostate Cancer Prostatic Dis. 2024 Oct 22. doi: 10.1038/s41391-024-00900-5. Online ahead of print. Prostate Cancer Prostatic Dis. 2024. PMID: 39438691 Review.
Robot-assisted Single-port Radical Prostatectomy with the SHURUI SP and da Vinci SP Platforms: Comparison of the Technology, Intraoperative Performance, and Outcomes.
Wu Z, Wang Z, Moschovas MC, Bertolo R, Campi R, Rivas JG, Wei Y, Xia D, Xu B, Zhu Q, Teoh JY, Gandaglia G, Amparore D, Porpiglia F, Patel V, Wang L. Wu Z, et al. Among authors: campi r. Eur Urol Open Sci. 2024 Jul 17;67:26-37. doi: 10.1016/j.euros.2024.07.107. eCollection 2024 Sep. Eur Urol Open Sci. 2024. PMID: 39113717 Free PMC article.
Diagnostic and prognostic factors in patients with prostate cancer: a systematic review.
Beyer K, Moris L, Lardas M, Haire A, Barletta F, Scuderi S, Molnar M, Herrera R, Rauf A, Campi R, Greco I, Shiranov K, Dabestani S, van den Broeck T, Arun S, Gacci M, Gandaglia G, Omar MI, MacLennan S, Roobol MJ, Farahmand B, Vradi E, Devecseri Z, Asiimwe A, Zong J, Maclennan SJ, Collette L, NDow J, Briganti A, Bjartell A, Van Hemelrijck M; the PIONEER Consortium. Beyer K, et al. Among authors: campi r. BMJ Open. 2022 Apr 4;12(4):e058267. doi: 10.1136/bmjopen-2021-058267. BMJ Open. 2022. PMID: 35379637 Free PMC article.
377 results